PF-Atlas › Clinical Trials › NCT02555059

Special Drug Use Investigation of Ciproxan Injection in Pediatrics

Cipro · Not specified

Registry ID

NCT02555059

Phase

Not specified

Status

Completed

Drug / intervention

Cipro (Ciprofloxacin, BAYQ3939)

Sponsor

Bayer

Start

2016-07-15

Enrollment

Locations

About this trial

The objective in this study is collecting post-marketing information on the safety and efficacy of Ciproxan injection under the routine clinical practice.

View NCT02555059 on ClinicalTrials.gov →

Explore related

All Cipro trials All IPF trials

Medical disclaimer. This page summarizes public trial data for NCT02555059 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.